Evergreen Theragnostics

Evergreen Theragnostics is a Springfield, New Jersey radiopharmaceutical company founded in 2019 that operates a cGMP contract development and manufacturing organization (CDMO) for therapeutic and diagnostic radiopharmaceuticals, alongside its own clinical pipeline of theragnostic pairs including the OCTEVY PET diagnostic imaging agent for neuroendocrine tumors. Its 14,000 square foot Springfield facility carries seven commercial-scale production suites, sterility lines, quality control and packaging space serving radioligand therapy developers. Lantheus Holdings completed its acquisition of the company on April 1, 2025, and Evergreen now operates as part of Lantheus. The company sells manufacturing services and drug products, not software: it publishes no developer program, no public API, and no machine-readable specifications.

Evergreen Theragnostics is profiled on the APIs.io network. Tagged areas include Company, Health Care, Pharmaceuticals, Life Sciences, and Manufacturing.

Evergreen Theragnostics’ developer surface includes engineering blog and 8 more developer resources.

🌐 Visit website 📡 Source on GitHub

10.8/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0

0 APIs

CompanyHealth CarePharmaceuticalsLife SciencesManufacturingRadiopharmaceuticalsOncologyContract ManufacturingMedical Imaging

Kin Score

Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0

Composite quality — 10.8/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.4 / 17

Commercial Clarity 3.6 / 17

Operational Transparency 0.0 / 11

Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 2.6 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/evergreen-theragnostics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Company 5

The organization behind the API

Website

About

Blog

BlogRSS

LinkedIn

Other 1

Properties that don't map to a standard resource type

SecondaryMarket

SecondaryMarket

Source (apis.yml)

aid: evergreen-theragnostics
name: Evergreen Theragnostics
description: 'Evergreen Theragnostics is a Springfield, New Jersey radiopharmaceutical company founded in 2019 that operates
  a cGMP contract development and manufacturing organization (CDMO) for therapeutic and diagnostic radiopharmaceuticals, alongside
  its own clinical pipeline of theragnostic pairs including the OCTEVY PET diagnostic imaging agent for neuroendocrine tumors.
  Its 14,000 square foot Springfield facility carries seven commercial-scale production suites, sterility lines, quality control
  and packaging space serving radioligand therapy developers. Lantheus Holdings completed its acquisition of the company on
  April 1, 2025, and Evergreen now operates as part of Lantheus. The company sells manufacturing services and drug products,
  not software: it publishes no developer program, no public API, and no machine-readable specifications.'
image: https://www.evergreentgn.com/wp-content/uploads/evergreen-theragnostics-og-img.jpg
url: https://raw.githubusercontent.com/api-evangelist/evergreen-theragnostics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-12'
modified: '2026-08-12'
tags:
- Company
- Health Care
- Pharmaceuticals
- Life Sciences
- Manufacturing
- Radiopharmaceuticals
- Oncology
- Contract Manufacturing
- Medical Imaging
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/evergreen-theragnostics-domain-security.yml
- type: Website
  url: https://www.evergreentgn.com/
- type: About
  url: https://www.evergreentgn.com/about-us/
- type: Blog
  url: https://www.evergreentgn.com/news/
- type: BlogRSS
  url: https://www.evergreentgn.com/feed/
- type: PrivacyPolicy
  url: https://www.evergreentgn.com/privacy-policy
- type: TermsOfService
  url: https://www.evergreentgn.com/terms-of-use
- type: LinkedIn
  url: https://www.linkedin.com/company/evergreentgn
- type: SecondaryMarket
  url: https://forgeglobal.com/evergreen-theragnostics_stock/
x-acquired-by:
  company: Lantheus Holdings, Inc.
  date: '2025-04-01'
  source: https://lantheusholdings.gcs-web.com/news-releases/news-release-details/lantheus-completes-acquisition-evergreen-theragnostics
x-enrichment:
  date: '2026-08-12'
  status: minimal
  artifacts_added: 2
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Evergreen Theragnostics is a cGMP radiopharmaceutical CDMO and drug developer whose product is manufactured radioligand
    doses, not software — its six-page WordPress marketing site has no developer, docs, or api subdomain (all three fail to
    resolve in DNS), no GitHub organization, and every /.well-known/ path returns the theme 404 page.
  evidence:
  - url: https://www.evergreentgn.com/.well-known/agent-card.json
    status: 404
  - url: https://www.evergreentgn.com/openapi.json
    status: 404
  - url: https://www.evergreentgn.com/llms.txt
    status: 404
  - url: https://api.github.com/orgs/evergreentgn
    status: 404
  checked: '2026-08-12'